Short Interest in The Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (NASDAQ:CGABL) Decreases By 73.5%

The Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (NASDAQ:CGABL) saw a large decrease in short interest during the month of August. As of August 15th, there was short interest totalling 2,200 shares, a decrease of 73.5% from the July 31st total of 8,300 shares. Based on an average daily volume of 19,600 shares, the days-to-cover ratio is currently 0.1 days.

Carlyle Group Inc. 4.625% Subordinated Notes due 2061 Stock Up 1.2 %

Carlyle Group Inc. 4.625% Subordinated Notes due 2061 stock traded up $0.24 during trading hours on Wednesday, hitting $19.80. The stock had a trading volume of 29,608 shares, compared to its average volume of 20,596. The stock’s 50-day moving average price is $18.64 and its 200-day moving average price is $18.81. Carlyle Group Inc. 4.625% Subordinated Notes due 2061 has a 12-month low of $15.60 and a 12-month high of $20.75.

Carlyle Group Inc. 4.625% Subordinated Notes due 2061 Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, August 15th. Investors of record on Thursday, August 1st were given a $0.2891 dividend. The ex-dividend date of this dividend was Thursday, August 1st. This represents a $1.16 annualized dividend and a yield of 5.84%.

About Carlyle Group Inc. 4.625% Subordinated Notes due 2061

biohaven is engaged in the identification and development of clinical stage compounds targeting the glutamatergic system. biohaven obtained licenses from yale university school of medicine and massachusetts general hospital regarding intellectual property relating to the use of certain glutamate modulating agents in the treatment of neuropsychiatric disorders.